Strategies for Blood Management in High-Risk Patients Undergoing Cardiothoracic Surgery CME

Author Information and Disclosures

Release Date: June 26, 2008; Valid for credit through June 26, 2009

Credits Available
Physicians - maximum of 0.5 AMA PRA Category 1 Credit(s)™ for physicians

To participate in this internet activity: (1) review the target audience, learning objectives, and author disclosures; (2) study the education content; (3) take the post-test and/or complete the evaluation; (4) view/print certificate View details.

Contents of This CME Activity

Legal Disclaimer

The material presented here does not necessarily reflect the views of Medscape or companies that support educational programming on www.medscape.com. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity.

Copyright © 2008 Medscape.
Bayer Healthcare
Learning Objectives

Upon completion of this activity, participants will be able to:

  1. Gain insight into the importance of preoperative identification of patients at high risk of bleeding in cardiothoracic surgery
  2. Review risk factors that can predispose patients to excessive bleeding
  3. Discuss a multimodality approach for blood management that can limit bleeding and blood transfusion
Authors and Disclosures

Victor A. Ferraris, MD, PhD
Disclosure: Victor A. Ferraris, MD, PhD, has disclosed that he has served as an advisor of consultant for Bayer. Dr. Ferraris has also disclosed that he has served as a speaker for BMS and sanofi-aventis.


Jerrold Levy, MD, FAHA
Disclosure: Jerrold Levy, MD, FAHA, has disclosed that he has received grants for clinical research from Medco. Dr. Levy has also disclosed that he served as a consultant for Alexion Pharmaceuticals, Bayer, Dyax, Novo Nordisk, CSL Behring.


John W. Hammon, Jr, MD
Disclosure: John W. Hammon, Jr, MD, has disclosed that he received grants for clinical research from Medtronic and Edwards Laboratories-Emblex.


Jayashree Gokhale, PhD
Disclosure: Jayashree Gokhale, PhD, has disclosed no relevant financial relationships.


Ariana Del Negro
Disclosure: Ariana Del Negro has disclosed no relevant financial relationships.


David Good
Disclosure: David Good has disclosed no relevant financial relationships.
 
Medscape
Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Medscape, LLC designates this educational activity for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Contact This Provider

All material on this website is protected by copyright, Copyright © 1994-2008 by Medscape. This website also contains material copyrighted by 3rd parties.